JP2024519515A5 - - Google Patents
Info
- Publication number
- JP2024519515A5 JP2024519515A5 JP2023561608A JP2023561608A JP2024519515A5 JP 2024519515 A5 JP2024519515 A5 JP 2024519515A5 JP 2023561608 A JP2023561608 A JP 2023561608A JP 2023561608 A JP2023561608 A JP 2023561608A JP 2024519515 A5 JP2024519515 A5 JP 2024519515A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- cell
- cells
- ipsc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163171646P | 2021-04-07 | 2021-04-07 | |
| US63/171,646 | 2021-04-07 | ||
| US202163279837P | 2021-11-16 | 2021-11-16 | |
| US63/279,837 | 2021-11-16 | ||
| PCT/US2022/022793 WO2022216514A1 (en) | 2021-04-07 | 2022-03-31 | Compositions and methods for generating gamma-delta t cells from induced pluripotent stem cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519515A JP2024519515A (ja) | 2024-05-15 |
| JP2024519515A5 true JP2024519515A5 (https=) | 2025-04-08 |
Family
ID=81648414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023561608A Pending JP2024519515A (ja) | 2021-04-07 | 2022-03-31 | 人工多能性幹細胞からガンマ－デルタｔ細胞を生成するための組成物および方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220333073A1 (https=) |
| EP (1) | EP4320227A1 (https=) |
| JP (1) | JP2024519515A (https=) |
| KR (1) | KR20230170703A (https=) |
| AU (1) | AU2022252997A1 (https=) |
| BR (1) | BR112023018844A2 (https=) |
| CA (1) | CA3214045A1 (https=) |
| IL (1) | IL307358A (https=) |
| MX (1) | MX2023011927A (https=) |
| TW (1) | TW202305113A (https=) |
| WO (1) | WO2022216514A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230118887A (ko) | 2020-12-03 | 2023-08-14 | 센츄리 쎄라퓨틱스 인코포레이티드 | 유전자 조작 세포 및 이의 용도 |
| CN116964194A (zh) * | 2021-02-05 | 2023-10-27 | 国立大学法人神户大学 | 诱导性多能干细胞衍生的γδT细胞及其产生方法 |
| IL314801A (en) | 2022-02-22 | 2024-10-01 | Juno Therapeutics Inc | Proteinase 3 (PR3) Chimeric Autoantigen Receptor T Cells and Related Methods and Uses |
| JP2025522360A (ja) | 2022-06-08 | 2025-07-15 | センチュリー セラピューティクス，インコーポレイテッド | Ｃｄ１６変異体およびｎｋｇ２ｄを発現する遺伝子操作した細胞ならびにその使用 |
| AU2023375625A1 (en) | 2022-11-10 | 2025-05-15 | Century Therapeutics, Inc. | Genetically engineered cells having anti-nectin4 chimeric antigen receptors, and uses thereof |
| WO2024191989A1 (en) * | 2023-03-14 | 2024-09-19 | Shattuck Labs, Inc. | Treatment of b cell-mediated diseases by activating cd20-targeted gamma delta t cells |
| WO2024206992A2 (en) * | 2023-03-30 | 2024-10-03 | Yale University | Universal antibody receptors, guar-t cells and therapeutic use thereof |
| WO2024254013A1 (en) * | 2023-06-04 | 2024-12-12 | Cytovia Therapeutics, Llc. | Natural killer cells with novel il-15 knock-in and methods of use thereof |
| WO2025101938A2 (en) | 2023-11-10 | 2025-05-15 | Century Therapeutics, Inc. | Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof |
| WO2025106626A1 (en) | 2023-11-15 | 2025-05-22 | Century Therapeutics, Inc. | Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof |
| CN118845737A (zh) * | 2024-07-08 | 2024-10-29 | 海南大学 | 托瑞米芬在增强γδT细胞抗肿瘤功能中的应用 |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6344321B1 (en) | 1990-06-11 | 2002-02-05 | Gilead Sciences, Inc. | Nucleic acid ligands which bind to hepatocyte growth factor/scatter factor (HGF/SF) or its receptor c-met |
| DK1621554T4 (da) | 1992-08-21 | 2012-12-17 | Univ Bruxelles | Immunoglobuliner blottet for lette kæder |
| GB9710807D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| US6140081A (en) | 1998-10-16 | 2000-10-31 | The Scripps Research Institute | Zinc finger binding domains for GNN |
| US6453242B1 (en) | 1999-01-12 | 2002-09-17 | Sangamo Biosciences, Inc. | Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| JP2002060786A (ja) | 2000-08-23 | 2002-02-26 | Kao Corp | 硬質表面用殺菌防汚剤 |
| JP2005500061A (ja) | 2001-08-20 | 2005-01-06 | ザ スクリップス リサーチ インスティテュート | Ｃｎｎについての亜鉛フィンガー結合ドメイン |
| US7888121B2 (en) | 2003-08-08 | 2011-02-15 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US7972854B2 (en) | 2004-02-05 | 2011-07-05 | Sangamo Biosciences, Inc. | Methods and compositions for targeted cleavage and recombination |
| US8574179B2 (en) | 2004-09-17 | 2013-11-05 | Stp Swiss Therapeutic Products Ag | Enhanced biomechanical stimulation device |
| JP5813321B2 (ja) | 2007-03-23 | 2015-11-17 | ウィスコンシン アラムニ リサーチ ファンデーション | 体細胞の再プログラム化 |
| EP3279314A1 (en) | 2008-06-04 | 2018-02-07 | Cellular Dynamics International, Inc. | Methods for the production of ips cells using non-viral approach |
| DK2356221T3 (en) | 2008-10-24 | 2019-02-18 | Wisconsin Alumni Res Found | Pluripotent stem cells obtained by non-viral reprogramming |
| KR101720961B1 (ko) | 2009-02-27 | 2017-03-29 | 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 | 다능성 세포의 분화 |
| US9056841B2 (en) | 2009-03-19 | 2015-06-16 | The Johns Hopkins University | PSMA-targeting compounds and uses thereof |
| WO2011072246A2 (en) | 2009-12-10 | 2011-06-16 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| US9206394B2 (en) | 2010-02-03 | 2015-12-08 | The University Of Tokyo | Method for reconstructing immune function using pluripotent stem cells |
| CA2806858C (en) | 2010-08-04 | 2021-06-15 | Cellular Dynamics International, Inc. | Reprogramming immortalized b cells |
| CA2826386C (en) | 2011-02-08 | 2020-04-28 | FUJIFILM Cellular Dynamics, Inc. | Hematopoietic precursor cell production by programming |
| DE102012006356A1 (de) | 2012-03-28 | 2013-10-02 | Audi Ag | Kraftfahrzeug, umfassend mehrere aktive oder passive Sicherheitsvorrichtungen |
| US9932607B2 (en) | 2013-11-15 | 2018-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Site-specific integration of transgenes into human cells |
| US11124845B2 (en) | 2014-03-18 | 2021-09-21 | The Johns Hopkins University | PSMA-based molecular-genetic reporter system |
| JP6715482B2 (ja) | 2014-07-18 | 2020-07-01 | 国立大学法人京都大学 | 多能性幹細胞から免疫細胞療法用ｔ細胞を誘導する方法 |
| US10947502B2 (en) | 2015-10-20 | 2021-03-16 | FUJIFILM Cellular Dynamics, Inc. | Methods for directed differentiation of pluripotent stem cells to immune cells |
| AU2016361451B2 (en) * | 2015-11-27 | 2024-01-25 | Cartherics Pty. Ltd. | Genetically modified cells and uses thereof |
| LT3444334T (lt) | 2016-04-15 | 2021-12-10 | Kyoto University | Antigenui specifinių cd8 teigiamų t ląstelių indikavimo būdas |
| KR20230167769A (ko) | 2016-08-26 | 2023-12-11 | 베이롤 칼리지 오브 메드신 | 세포 치료요법을 위한 항상성 활성 사이토킨 수용체 |
| US11525119B2 (en) | 2016-09-06 | 2022-12-13 | The Children's Medical Center Corporation | Immune cells derived from induced pluripotent stem cell |
| CN109996868A (zh) | 2016-09-23 | 2019-07-09 | 弗雷德哈钦森癌症研究中心 | 特异性用于次要组织相容性(h)抗原ha-1的tcr及其用途 |
| AU2017340644B2 (en) | 2016-10-05 | 2024-05-09 | FUJIFILM Cellular Dynamics, Inc. | Methods for directed differentiation of pluripotent stem cells to HLA homozygous immune cells |
| CN110199017A (zh) * | 2017-01-20 | 2019-09-03 | 国立大学法人京都大学 | CD8α+β+细胞毒性T细胞的制备方法 |
| JP7224021B2 (ja) * | 2017-02-03 | 2023-02-17 | 国立大学法人神戸大学 | 人工多能性幹細胞の作製方法 |
| MX2019012017A (es) | 2017-04-07 | 2020-02-12 | Juno Therapeutics Inc | Celulas modificadas que expresan antigeno de membrana especifico de prostata (psma) o una forma modificada del mismo y metodos relacionados. |
| SG11201909331UA (en) | 2017-04-18 | 2019-11-28 | Fujifilm Cellular Dynamics Inc | Antigen-specific immune effector cells |
| CA3070998A1 (en) | 2017-07-25 | 2019-01-31 | Board Of Regents, The University Of Texas System | Enhanced chimeric antigen receptors and use thereof |
| WO2019060695A1 (en) | 2017-09-22 | 2019-03-28 | Kite Pharma, Inc. | CHIMERIC POLYPEPTIDES AND USES THEREOF |
| EP4269560A3 (en) | 2017-10-03 | 2024-01-17 | Precision Biosciences, Inc. | Modified epidermal growth factor receptor peptides for use in genetically-modified cells |
| JP2021505131A (ja) * | 2017-12-08 | 2021-02-18 | フェイト セラピューティクス，インコーポレイテッド | 増強されたｉＰＳＣ由来のエフェクター細胞を用いた免疫療法 |
| TW202020145A (zh) * | 2018-07-13 | 2020-06-01 | 國立大學法人京都大學 | γδＴ細胞的製造方法 |
| WO2020061256A1 (en) | 2018-09-19 | 2020-03-26 | FUJIFILM Cellular Dynamics, Inc. | Protein l for activation and expansion of chimeric antigen receptor-modified immune cells |
| AU2019372673A1 (en) * | 2018-11-01 | 2021-05-27 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Compositions and methods for T cell engineering |
| CA3205479A1 (en) * | 2020-12-28 | 2022-07-07 | The Regents Of The University Of California | Engineered gamma delta t cells and methods of making and using thereof |
-
2022
- 2022-03-31 BR BR112023018844A patent/BR112023018844A2/pt unknown
- 2022-03-31 WO PCT/US2022/022793 patent/WO2022216514A1/en not_active Ceased
- 2022-03-31 KR KR1020237038118A patent/KR20230170703A/ko active Pending
- 2022-03-31 JP JP2023561608A patent/JP2024519515A/ja active Pending
- 2022-03-31 IL IL307358A patent/IL307358A/en unknown
- 2022-03-31 EP EP22723243.6A patent/EP4320227A1/en active Pending
- 2022-03-31 MX MX2023011927A patent/MX2023011927A/es unknown
- 2022-03-31 AU AU2022252997A patent/AU2022252997A1/en active Pending
- 2022-03-31 CA CA3214045A patent/CA3214045A1/en active Pending
- 2022-04-04 US US17/657,798 patent/US20220333073A1/en active Pending
- 2022-04-07 TW TW111113220A patent/TW202305113A/zh unknown
-
2024
- 2024-09-16 US US18/886,563 patent/US20250066728A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024519515A5 (https=) | ||
| US12233090B2 (en) | Bispecific or-gate chimeric antigen receptor responsive to CD20 and CD19 | |
| US20250002579A1 (en) | Chimeric antigen receptors and methods of making | |
| US20250034217A1 (en) | Nucleic acid constructs for co-expression of chimeric antigen receptor and transcription factor, cells containing and therapeutic use thereof | |
| US12060585B2 (en) | Expression of novel cell tags | |
| JP2024513906A5 (https=) | ||
| US12304935B2 (en) | Immunomodulatory polypeptides and related compositions and methods | |
| JP2023553419A5 (https=) | ||
| JP2022553818A (ja) | 二重標的キメラ抗原レセプターｔ細胞療法のためのプロテアーゼスイッチ | |
| TWI862531B (zh) | 突變型piggyBac轉位酶 | |
| RS63574B1 (sr) | Metode za povećanje efikasnosti imuno ćelija | |
| WO2015028444A1 (en) | Anti cd30 chimeric antigen receptor and its use | |
| JP2025501214A5 (https=) | ||
| TW202300528A (zh) | 嵌合抗原受體 | |
| WO2024193714A1 (zh) | 细胞免疫疗法的组合物和方法 | |
| EP4615960A1 (en) | Methods for manufacturing engineered immune cells | |
| CN115397863A (zh) | Cd3融合蛋白及其用途 | |
| HK40115184A (en) | Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20 | |
| CN119331823A (zh) | 用于工程化t细胞制备的病毒颗粒及其用途 | |
| JP2024545870A (ja) | 血小板減少症を治療するための製品及び方法 | |
| CN117778328A (zh) | 一种通用型bcma car-t细胞的增殖方法 | |
| CN121800931A (zh) | 靶向cll1的增强型嵌合抗原受体及其应用 | |
| KR20260022392A (ko) | 융합 단백질 및 그의 의학적 용도 | |
| CN116157415A (zh) | 靶向抗rh抗体的组合物和方法 | |
| HK40030175A (en) | Chimeric antigen receptors and methods of making |